AD816
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AD816, covering 2023-11-15 to 2023-11-15. Get the full timeline:
Most recent: Clinical Trial Update: AD816 Crossover Study [Phase 2]
1 regulatory and trial event tracked for AD816, covering 2023-11-15 to 2023-11-15. Get the full timeline:
Most recent: Clinical Trial Update: AD816 Crossover Study [Phase 2]